Topics

High-grade gliomas | Treatment | Targeted therapy | SYHA1813

Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > SYHA1813

Kang Z, Li S, Wang L, Chen Q, Hu W, Lei T, Mao Y, Zhang J, Xiang X, Wang Q, He Z, Sun T, Wang Y, Huang M, Zhang R, Chen F, Li W.
SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High-Grade Gliomas: A Multicenter, Open-Label Phase I Study.
Ann Clin Transl Neurol. 2025 Aug 22. doi: 10.1002/acn3.70166. PMID: 40847460. Interventional study. ˍ ChiCTR.org.cn ID: ChiCTR2100045380.